Literature DB >> 8349038

Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein.

J Ferrer1, R Gomis, J Fernández Alvarez, R Casamitjana, E Vilardell.   

Abstract

Pancreatic islet GLUT2 mRNA is known to be regulated in vitro and in vivo by glucose. We have investigated several potential mechanisms mediating the response of islet GLUT2 to glucose. GLUT2 mRNA and protein were measured from isolated rat islets cultured for up to 24 h under selected conditions. Glucose at 11 mM stimulated GLUT2 mRNA 10-fold compared with 2 mM glucose, with no additional increase at 16.7 mM glucose, whereas maximal 4-fold induction of the protein was attained with 16 mM glucose. Time course studies showed a 2.5-fold induction of GLUT2 mRNA apparent after only 8 h of culture at 16.7 mM glucose. Glycolysis inhibitor mannoheptulose suppressed the stimulatory effect of 16.7 mM glucose on GLUT2 mRNA and protein. Metabolizable sugars mannose and glyceraldehyde enhanced transporter mRNA levels, in contrast with the lack of stimulation by nonmetabolizable 2-deoxy-D-glucose. Stimulation by different sugars and glycolysis inhibition led to analogous changes of proinsulin mRNA, suggesting that common signaling mechanisms are shared in glucose regulation of proinsulin and GLUT2 gene expression. Preexposure to mannoheptulose, however, failed to suppress glucose-stimulated insulin release. Tunicamycin, a glycoprotein synthesis inhibitor, did not block the effect of 16 mM glucose on GLUT2 mRNA levels. RNA and protein synthesis inhibitors actinomycin and cycloheximide abolished the enhancing effects of high glucose on GLUT2 mRNA. These findings indicate that glucose metabolism, but not glycoprotein synthesis or substrate interaction with the transporter protein, is instrumental in the stimulatory effects of glucose on beta-cell GLUT2 mRNA accumulation. In addition, ongoing RNA and protein synthesis are required for this effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349038     DOI: 10.2337/diab.42.9.1273

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes.

Authors:  F Rencurel; G Waeber; C Bonny; B Antoine; P Maulard; J Girard; A Leturque
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

2.  Gene expression profiles during beta cell maturation and after IL-1beta exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1beta sensitivity.

Authors:  K Nielsen; M Kruhøffer; T Orntoft; T Sparre; H Wang; C Wollheim; M C Jørgensen; J Nerup; A E Karlsen
Journal:  Diabetologia       Date:  2004-12-17       Impact factor: 10.122

3.  Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK.

Authors:  Chirag Patel; Veronique Douard; Shiyan Yu; Phuntila Tharabenjasin; Nan Gao; Ronaldo P Ferraris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-17       Impact factor: 3.619

4.  Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets.

Authors:  M Párrizas; M A Maestro; S F Boj; A Paniagua; R Casamitjana; R Gomis; F Rivera; J Ferrer
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Homocysteine Metabolism Pathway Is Involved in the Control of Glucose Homeostasis: A Cystathionine Beta Synthase Deficiency Study in Mouse.

Authors:  Céline Cruciani-Guglielmacci; Kelly Meneyrol; Jessica Denom; Nadim Kassis; Latif Rachdi; Fatna Makaci; Stéphanie Migrenne-Li; Fabrice Daubigney; Eleni Georgiadou; Raphaël G Denis; Ana Rodriguez Sanchez-Archidona; Jean-Louis Paul; Bernard Thorens; Guy A Rutter; Christophe Magnan; Hervé Le Stunff; Nathalie Janel
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

6.  Effects of glucose refeeding and glibenclamide treatment on glucokinase and GLUT2 gene expression in pancreatic B-cells and liver from rats.

Authors:  M Tiedge; S Lenzen
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

7.  Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.

Authors:  Joan-Marc Servitja; Miguel Pignatelli; Miguel Angel Maestro; Carina Cardalda; Sylvia F Boj; Juanjo Lozano; Enrique Blanco; Amàlia Lafuente; Mark I McCarthy; Lauro Sumoy; Roderic Guigó; Jorge Ferrer
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

8.  Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver.

Authors:  F Rencurel; G Waeber; B Antoine; F Rocchiccioli; P Maulard; J Girard; A Leturque
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

9.  Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation.

Authors:  Cheng-Fang Hsieh; Ching-Kuan Liu; Ching-Tien Lee; Liang-En Yu; Jiz-Yuh Wang
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

Review 10.  Glucose transporters in pancreatic islets.

Authors:  Constantin Berger; Daniela Zdzieblo
Journal:  Pflugers Arch       Date:  2020-05-12       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.